Skip to main content

Sexual Health

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Promoting Awareness through Live Movement and Sound for youth with Autism Spectrum DisorderN/A1 trial
Active Trials
NCT04005547Terminated72Est. May 2020
Biomed
BiomedAustralia - Sydney
1 program
ShatavariN/A1 trial
Active Trials
NCT06972706Completed51Est. Feb 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiomedShatavari
Temple TherapeuticsPromoting Awareness through Live Movement and Sound for youth with Autism Spectrum Disorder

Clinical Trials (2)

Total enrollment: 123 patients across 2 trials

Efficacy and Safety of Shatavari in Women Sexual Wellness: A Prospective, Randomized, Double-Blind, Three-arm, Parallel, Placebo-Controlled Study

Start: Oct 2024Est. completion: Feb 202551 patients
N/ACompleted
NCT04005547Temple TherapeuticsPromoting Awareness through Live Movement and Sound for youth with Autism Spectrum Disorder

Health Education and Relationships Through Theater: An RCT of Promoting Awareness Through Live Movement and Sound for Youth With Autism Spectrum Disorder (PALMS-ASD)

Start: Sep 2017Est. completion: May 202072 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.